Atavistik Bio logo

Atavistik Bio Funding & Investors

Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms.

atavistikbio.com

Total Amount Raised: $100,000,000

Atavistik Bio Funding Rounds

  • Series Unknown

    $40,000,000

    Series Unknown Investors

    Column Group
    Nextech Invest
    Lux Capital
  • Series A

    $60,000,000

    Series A Investors

    Column Group
    Nextech Invest
    Lux Capital
Funding info provided by Diffbot.